Thrombopoietin administered during induction chemotherapy to patients with acute myeloid leukemia induces transient morphologic changes that may resemble chronic myeloproliferative disorders

American Journal of Clinical Pathology

Volumn 117, Issue 6, 2002, Pages 844-850

  Douglas, Vonda K ^a   Tallman, Martin S ^a   Cripe, Larry D ^a   Peterson, LoAnn C ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Bone marrow; Megakaryocyte; Myeloproliferative disorder; Thrombopoietin

Indexed keywords

CYTARABINE; IDARUBICIN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; THROMBOPOIETIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW CELL; CELL HYPERPLASIA; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; EMPERIPOLESIS; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOCYTOSIS; MEGAKARYOPOIESIS; MITOSIS; MYELOPHTHISIC ANEMIA; MYELOPROLIFERATIVE DISORDER; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOCYTOSIS;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BONE MARROW; DRUG THERAPY, COMBINATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA, MYELOID; MEGAKARYOCYTES; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; NEOADJUVANT THERAPY; RETROSPECTIVE STUDIES; THROMBOPOIETIN;

EID: 0036263664     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/09NP-3DFG-BLM9-E5LE     Document Type: Article

References (29)

1. Demonstration and some properties of human thrombopoietin in thrombocythemic sera
2. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand
3. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo
4. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin
5. c-Mpl ligand is a humoral regulator of megakaryocytopoiesis
6. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl
7. Thrombopoietin and the hematopoietic stem cell
8. The effects of thrombo-poietin on megakaryocyte-cfc, megakaryocytes, and thrombo-poiesis: With studies of ploidy and platelet size
9. Megakaryocytes increase in size within ploidy groups in response to the stimulus of thrombocytopenia
10. Thrombopoietin: In vitro predictions, in vivo realities
11. Thrombopoietin
12. Thrombopoietin: The primary regulator of platelet production
13. Thrombopoietin, the Mpl ligand is essential for full megakaryocyte development
14. Systemic hematologic effects of PEG-rHuMGDF-induced megakaryocyte hyperplasia in mice
15. Prevention of thrombocytopenia and neutropenia in a non-human primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor
16. Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy
17. Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice
18. The haemato-poietic effects of thrombopoietin administered post-myelo-suppressive carboplatin therapy compared to either pre- and post- or pre-chemotherapy
19. Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice
20. Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers
21. Effects of polyethylene glycol-conjugated recombinant human megakaryocytic growth and development factor on platelet counts after chemotherapy for lung cancer
22. A double-blind study, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemia
23. A pilot study of recombinant human thrombopoietin (rhTPO) and GM-CSF following induction therapy in patients older than 55 years with acute myeloid leukemia (AML)
24. Proposed revised criteria for the classification of acute myeloid leukemia
25. Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis
26. Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts
27. A model of myelofibrosis and osteosclerosis in mice induced by overexpression of thrombopoietin (mpl ligand): Reversal of disease by bone marrow transplantation
28. Dysmegakaryopoiesis resembling acute megakaryoblastic leukemia in treated acute myeloid leukemia
29. Chronic myeloproliferative disorders